Siddharth Singh
University of California San Diego
Appearances
- DateMay 9, 2023AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…
Moderator
University of California San Diego - DateMay 9, 2023AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…
Presenter
University of California San Diego - DateMay 9, 2023AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…
Presenters
University of California San Diego - DateMay 8, 2023Barrett’s esophagus (BE), a pre-malignant precursor of esophageal adenocarcinoma (EAC), when recognized early through screening, could potentially allow for endoscopic surveillance or endoscopic eradication therapy…
Presenter
UH Cleveland Medical CenterSpeakers
University of California San DiegoUniversity of California San DiegoUniversity of California San Diego - DateMay 9, 2023BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
Presenter
University of California San DiegoSpeakers
Dartmouth-Hitchcock Medical Center - DateMay 20, 2024
Presenter
University of California San Diego - DateMay 20, 2024
Presenters
University of Central Lancashire, UKUniversity of California San Diego - DateMay 19, 2024SOCIETY: AGA AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…
Moderators
University of California San DiegoWashington University in St Louis - DateMay 19, 2024
Presenters
Massachusetts General HospitalUniversity of California San Diego - DateMay 18, 2024
Presenter
University of California San Diego - DateMay 18, 2024
Presenters
Katholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenNorthwestern University Feinberg School of MedicineUniversity of California San DiegoUniversity Hospitals Leuven INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASES IN HISPANICS IN THE UNITED STATES, 2011-2020
DateMay 19, 2024BACKGROUND & AIMS: Hispanics account for 19% (62 million) of the US population, of whom 2/3rd are US born; with global and regional immigration patterns, Hispanics are expected to increase to 30% of the US population (111 million) by 2060…Presenter
University of California San DiegoSpeakers
- DateMay 19, 2024Patients with inflammatory bowel disease (IBD) are at an increased risk for vaccine-preventable diseases, such as herpes zoster (HZ). The aim of this study was to determine whether complications of HZ are more frequent in patients with IBD than in non-IBD controls…
Presenter
University of WisconsinSpeakers
University of California San DiegoMayo Clinic in FloridaMayo Clinic - DateMay 20, 2024BACKGROUND: Despite older adults making up roughly one quarter of patients with inflammatory bowel disease (IBD) in the United States, they are an understudied population…
Presenter
Speakers
NYU Langone HealthDartmouth-Hitchcock Medical CenterUniversity of California San Diego - DateMay 6, 2025LIVE STREAM SESSION AGA guidelines are rigorous evidence-based and trusted guidelines in the field of GI and hepatology…
Moderators
University of California San DiegoWashington University in St Louis